Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HERITAGE

  • FDA Approval
  • April 24, 2025, 08:49 UTC
  • 65
  • 0 comments

FDA approve HYDRALAZINE HYDROCHLORIDE

Comment Full text

APOTEX INC

  • FDA Approval
  • April 24, 2025, 08:49 UTC
  • 65
  • 0 comments

FDA approve AXITINIB

Comment Full text

PFIZER

  • FDA Approval
  • April 24, 2025, 08:49 UTC
  • 64
  • 0 comments

FDA approve CABERGOLINE

Comment Full text

MIRUM

  • FDA Approval
  • April 21, 2025, 14:42 UTC
  • 76
  • 0 comments

FDA approve MARALIXIBAT

Comment Full text

Premier Research Consulting, LLC

  • FDA Approval
  • April 21, 2025, 14:28 UTC
  • 76
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 56
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

LEADING

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 64
  • 0 comments

FDA approve FROVATRIPTAN SUCCINATE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 54
  • 0 comments

FDA approve FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 66
  • 0 comments

FDA approve CARBIDOPA; ENTACAPONE; LEVODOPA

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 69
  • 0 comments

FDA approve RANOLAZINE

Comment Full text
  • Previous
  • 195
  • 196
  • 197
  • 198
  • 199
  • Next

Search

News categories

  • Technical Exchange News(13517)
  • Event(6229)
  • SEC News(351094)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(192837)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin